CareRx Corp Valuation
CRRX Stock | CAD 1.89 0.01 0.53% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. CareRx Corp shows a prevailing Real Value of C$1.63 per share. The current price of the firm is C$1.89. Our model approximates the value of CareRx Corp from analyzing the firm fundamentals such as Return On Equity of -0.075, current valuation of 199.59 M, and Profit Margin of (0.02) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CareRx Corp's valuation include:
Price Book 1.491 | Enterprise Value 199.6 M | Enterprise Value Ebitda 8.3985 | Price Sales 0.3264 | Forward PE 12.5313 |
Overvalued
Today
Please note that CareRx Corp's price fluctuation is very risky at this time. Calculation of the real value of CareRx Corp is based on 3 months time horizon. Increasing CareRx Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CareRx Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CareRx Stock. However, CareRx Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.89 | Real 1.63 | Hype 1.9 |
The intrinsic value of CareRx Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CareRx Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CareRx Corp helps investors to forecast how CareRx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CareRx Corp more accurately as focusing exclusively on CareRx Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CareRx Corp's intrinsic value based on its ongoing forecasts of CareRx Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CareRx Corp's closest peers.
CareRx Corp Cash |
|
CareRx Valuation Trend
Knowing CareRx Corp's actual value is paramount for traders when making sound investment determinations. Using both CareRx Corp's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
CareRx Corp Total Value Analysis
CareRx Corp is currently estimated to have takeover price of 199.59 M with market capitalization of 119.36 M, debt of 97.52 M, and cash on hands of 28.37 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CareRx Corp fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
199.59 M | 119.36 M | 97.52 M | 28.37 M |
CareRx Corp Investor Information
About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. CareRx Corp recorded a loss per share of 0.1. The entity last dividend was issued on the 25th of June 2020. The firm had 1:20 split on the 25th of June 2020. Based on the analysis of CareRx Corp's profitability, liquidity, and operating efficiency, CareRx Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.CareRx Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CareRx Corp has an asset utilization ratio of 159.88 percent. This suggests that the Company is making C$1.6 for each dollar of assets. An increasing asset utilization means that CareRx Corp is more efficient with each dollar of assets it utilizes for everyday operations.CareRx Corp Ownership Allocation
CareRx Corp holds a total of 63.49 Million outstanding shares. Over half of CareRx Corp's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in CareRx Corp. Please watch out for any change in the institutional holdings of CareRx Corp as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CareRx Corp Profitability Analysis
The company reported the revenue of 370.75 M. Net Loss for the year was (5.41 M) with profit before overhead, payroll, taxes, and interest of 109.93 M.About CareRx Corp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CareRx Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CareRx Corp based exclusively on its fundamental and basic technical indicators. By analyzing CareRx Corp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CareRx Corp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CareRx Corp. We calculate exposure to CareRx Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CareRx Corp's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 84.7 M | 64.7 M | |
Pretax Profit Margin | (0.03) | (0.03) | |
Operating Profit Margin | 0.01 | 0.02 | |
Net Loss | (0.01) | (0.02) | |
Gross Profit Margin | 0.23 | 0.39 |
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.